EX-99.1 2 exhibit99-1.htm JOINT FILING APPLICATION BY AND AMONG THE REPORTING PERSONS
Exhibit 99.1

JOINT FILING APPLICATION
 
The undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the Common Stock, par value $0.0001 per share, of Agile Therapeutics, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
 
February 13, 2023

LIND GLOBAL FUND II LP
  
   
By:
Lind Global Partners II LLC
  
 
its General Partner
  
     
By:
/s/ Jeff Easton
  
Name:
Jeff Easton
  
Title:
Managing Member
  
   
LIND GLOBAL PARTNERS II LLC
   
By:
/s/ Jeff Easton
Name:
Jeff Easton
Title:
Managing Member
   
JEFF EASTON
  
   
By:
 
/s/ Jeff Easton